References
- 1
Zhou, P. et al. Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression. Nature Med. 3, 659–664 (1997).
- 2
Maciaszek, J.W. et al. IL-16 Represses HIV-1 Promoter Activity. J. Immunol. 158, 5–8 (1997).
- 3
Laberge, S. et al. Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation: Evidence for constitutive protein synthesis and storage. J. Immunol. 55, 2902–2910 (1995).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Viglianti, G., Parada, N., Maciaszek, J. et al. IL-16 anti-HIV-1 therapy. Nat Med 3, 938 (1997). https://doi.org/10.1038/nm0997-938
Issue Date:
Further reading
-
Cell surface receptors, virus entry and tropism of primate lentiviruses
Journal of General Virology (2002)
-
Human focal cerebral infarctions induce differential lesional interleukin-16 (IL-16) expression confined to infiltrating granulocytes, CD8+ T-lymphocytes and activated microglia/macrophages
Journal of Neuroimmunology (2001)
-
Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities
Antiviral Research (2000)
-
An African green monkey lacking peripheral CD4 lymphocytes that retains helper T cell activity and coexists with SIVagm
Clinical and Experimental Immunology (1999)
-
Interleukin-16 Inhibits Human Immunodeficiency Virus Type 1 Entry and Replication in Macrophages and in Dendritic Cells
Journal of Virology (1999)